and portfolio growth is accelerating. In 2022, Royalty Pharma announced a plan to complete acquisitions worth between $10 ...

Quality dividend growth stocks share several crucial characteristics that set them apart from other types of passive-income ...

The stock market's history is filled with both tremendous successes and sobering failures when it comes to growth stocks.

Royal Gold reports record Q3-24 results despite challenges, strong exploration portfolio, attractive valuation, and potential ...

Gold Royalty Corp is a promising investment opportunity with exposure to high-quality gold royalties and potential for growth ...

We do not undertake any obligation to update our forward-looking statements in light of new information or future ... also enhancing and extending our growth runway given the remaining undeveloped ...

Globally, lithium carbonate is produced from either lower-cost evaporation of brine or higher-cost mining of spodumene minerals. Albemarle has a cost advantage in lithium carbonate production due to ...

LandBridge Company LLC (NYSE: LB) (the “Company,” “LandBridge”) today announced its financial and operating results for the third quarter of 2024. (1) Net loss and net loss margin include a non-cash ...

Arm reported second-quarter revenue of $844 million, beating analyst estimates of $808.37 million, according to Benzinga Pro.

Dividend stocks are providing passive income for millions of investors who use the funds to help meet monthly budgets stressed from inflation.

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) (“KalVista”), today announced the closing of a synthetic royalty financing agreement with DRI Healthcare Trust (“DRI”) for up to $179 million, comprised ...

It was a good quarter for the fund fueled by precious metal royalty companies ... deep into our #1 AI stock’s groundbreaking ...